Ketamine reduces suicidality in depressed patients

Sep 10, 2009

Drug treatment options for depression can take weeks for the beneficial effects to emerge, which is clearly inadequate for those at immediate risk of suicide. However, intravenous (IV) ketamine, a drug previously used as an anesthetic, has shown rapid antidepressant effects in early trials.

Researchers have now explored ketamine's effects on suicidality in patients with treatment-resistant depression, and are publishing their results in the September 1st issue of Biological Psychiatry. Ketamine acutely reduced when patients were assessed 24 hours after a single infusion. This reduction in suicidality was maintained when patients received repeated doses over the next two weeks.

Corresponding author Rebecca Price commented on these encouraging findings: "If these findings hold up in larger samples of high-risk suicidal patients, IV could prove an attractive treatment option in situations where waiting for a conventional antidepressant treatment to take effect might endanger the patient's life."

Since this was a preliminary study in a small group of depressed patients, further research is needed to replicate these results. However, the findings are promising and could result in improved treatment for suicidal patients in the future.

More information: The article appears in , Volume 65, Issue 5 (September 1, 2009), published by Elsevier.

Source: Elsevier

Explore further: Alcohol makes smiles more 'contagious,' but only for men

add to favorites email to friend print save as pdf

Related Stories

Researchers explore the antidepressant effects of ketamine

Feb 21, 2008

Drug treatments for depression can take many weeks for the beneficial effects to emerge. The excruciating and disabling nature of depression highlights the urgency of developing treatments that act more rapidly. Ketamine, ...

Faster-acting antidepressants closer to becoming a reality

Jul 24, 2007

A new study has revealed more about how the medication ketamine, when used experimentally for depression, relieves symptoms of the disorder in hours instead of the weeks or months it takes for current antidepressants to work. ...

Regular follow-up important during antidepressant treatment

Nov 01, 2006

Because individuals can react differently to antidepressant medications, regular follow-up is important during the first few weeks of treatment, according to an editorial by Group Health psychiatrist and researcher Greg Simon, ...

Recommended for you

Omega-3 fatty acids may prevent some forms of depression

11 minutes ago

Patients with increased inflammation, including those receiving cytokines for medical treatment, have a greatly increased risk of depression. For example, a 6-month treatment course of interferon-alpha therapy ...

Ethical behavior can be contagious, study says

35 minutes ago

A new study from Penn State Smeal College of Business faculty members Steven Huddart and Hong Qu examines the power of social influence on managers' ethical behavior. The Department of Accounting researchers find that managers ...

Predicting the future course of psychotic illness

1 hour ago

University of Adelaide psychiatry researchers have developed a model that could help to predict a patient's likelihood of a good outcome from treatment – from their very first psychotic episode.

Boys will be boys? Yes, neuroscience now shows

12 hours ago

If you've ever tried to warn teenagers of the consequences of risky behavior - only to have them sigh and roll their eyes - don't blame them. Blame their brain anatomy.

Depression increasing across the country

16 hours ago

A study by San Diego State University psychology professor Jean M. Twenge shows Americans are more depressed now than they have been in decades.

User comments : 0